FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma
May 19, 2026
May 19, 2026
BUFFALO, New York, May 19 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma
*
BUFFALO, N.Y. -The U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation and Orphan Drug Designation to Canget BioTekpharma LLC, a Roswell Park spinoff company, for FL118, a novel an . . .
* * *
FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma
*
BUFFALO, N.Y. -The U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation and Orphan Drug Designation to Canget BioTekpharma LLC, a Roswell Park spinoff company, for FL118, a novel an . . .